NRBO READ THE FULL NRBO RESEARCH REPORT Business Update Topline Results from Phase 2a Trial of DA-1241 in MASH Expected in ...
CENDIFOX: Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX based therapies in pancreatic, colon and appendiceal cancers. The trial has completed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback